Next generation ALS drug silences inherited form of the disease in animal models

Researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations in SOD1.

from Health & Medicine News -- ScienceDaily https://ift.tt/2LTcuGq